A view from the Center

Deloitte's Life Sciences & Health Care Blog

Filter by category or month:

Can digital innovations in clinical research help recruit participants?

by Doug Beaudoin, Principal, Deloitte Consulting LLP

Low clinical trial recruitment rates can be a barrier for developing new treatments for certain conditions and patient populations. For patients, the clinical trial system can be tough to navigate; it can be difficult to find open trials, or figure out the patient criteria and what choices are available. These recruitment barriers can slow research progress and add costs for life sciences companies,

Read more

Hitting the target with targeted therapies: Challenges in advancing precision medicine

by Sonal Shah, Senior Manager, Deloitte Center for Health Solutions, Deloitte Services LP

Precision medicine – using genetic or molecular information to identify patients who could benefit from targeted treatments – could lead to more judicious use of therapies and improved patient outcomes. I recently attended a meeting where biopharma leaders discussed their precision medicine strategies. I was struck by the challenges they must overcome to bring precision medicine to the real world.

Read more

Cures Act: An important mile marker in the journey to treat disease

by Greg Reh, Vice Chairman, US and Global Life Sciences Leader, Deloitte LLP

On April 17, more than 30,000 people ran, walked, or wheeled the famed 26.2-mile route from Hopkinton, Massachusetts to Boston. Among them were people who used the event to raise money for charities focused on finding new and more effective treatments for diseases such as cancer and Multiple Sclerosis.

Like a marathon, the road to winning approval for ground-breaking pharmaceuticals and innovative medical devices can be arduous.

Read more

DNA-based Zika virus vaccine moves forward in US

by Doug Beaudoin, Principal, Deloitte Consulting LLP

The Zika virus that has caused an epidemic of birth defects in parts of Latin America and the Caribbean receded from the headlines here in the US once cooler weather rolled in last fall. But, as certain parts of the country gear up for mosquito season, public health officials are reminding residents and travelers to prepare and take precautions,

Read more

The Jetson’s drugstore: Welcome to the digitization of the pharmacy sector

by George Van Antwerp, Senior Manager, Deloitte Consulting LLP

A flying car that conveniently folds into a briefcase never materialized, but the digital revolution now underway in pharmacy could lead to a reality not far from the futuristic world envisioned by The Jetsons cartoon series of the 1970s.

As an industry, health care is often seeking ways to pay for and reward value rather than volume.

Read more

Despite changing political waters, there may be waves of opportunity for Medicaid

by Jim Hardy, Specialist Leader, State Health Transformation Services, Deloitte Consulting LLP

Efforts to repeal and replace elements of the Affordable Care Act (ACA) appeared adrift last month after House Republicans determined they didn’t have the votes to move the American Health Care Act (AHCA) forward. Recent reports indicate that Republican leaders are continuing conversations on reform options.1 Regardless of whether repeal and replace legislation sinks or sails,

Read more